Transhiatal distal esophagectomy for Siewert type II cardia cancer can be a treatment option in selected patients.

[1]  M. Feith,et al.  Influence of the surgical technique on survival in the treatment of carcinomas of the true cardia (Siewert Type II) - Right thoracoabdominal vs. transhiatal-abdominal approach. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  Kyoung-Mee Kim,et al.  Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer , 2018, Gastric Cancer.

[3]  R. Reddavid,et al.  Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? , 2018, World journal of gastroenterology.

[4]  J. Trojan,et al.  Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial , 2017, Zeitschrift für Gastroenterologie.

[5]  G. Verlato,et al.  Western strategy for EGJ carcinoma , 2017, Gastric Cancer.

[6]  P. Siersema,et al.  Surgical Treatment of Adenocarcinomas of the Gastro-esophageal Junction , 2015, Annals of Surgical Oncology.

[7]  M. Wei,et al.  Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis. , 2014, World journal of gastroenterology.

[8]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[9]  Ivan Biaggio,et al.  1,1‐Dicyano‐4‐[4‐(diethylamino)phenyl]buta‐1,3‐dienes: Structure–Property Relationships , 2012 .

[10]  J. Fléjou.  Classification OMS 2010 des tumeurs digestives : la quatrième édition☆ , 2011 .

[11]  J. Johansson,et al.  Two Different Surgical Approaches in the Treatment of Adenocarcinoma at the Gastroesophageal Junction , 2008, World Journal of Surgery.

[12]  J. Reitsma,et al.  Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus: Five-Year Survival of a Randomized Clinical Trial , 2007, Annals of surgery.

[13]  F. Roviello,et al.  Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. , 2007, The Journal of thoracic and cardiovascular surgery.

[14]  V. Rusch,et al.  Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome , 2007, Annals of surgery.

[15]  A. Nashimoto,et al.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. , 2006, The Lancet. Oncology.

[16]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[17]  S. Ashley,et al.  Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? , 2004, Journal of the American College of Surgeons.

[18]  J. V. van Sandick,et al.  Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia , 2002, The British journal of surgery.

[19]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[20]  C. Mariette,et al.  Surgical management of and long‐term survival after adenocarcinoma of the cardia , 2002, The British journal of surgery.

[21]  M. Feith,et al.  Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients , 2000, Annals of surgery.

[22]  C. Cortesini,et al.  Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma , 2000, Journal of surgical oncology.

[23]  W. Hop,et al.  Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity , 1999, The British journal of surgery.

[24]  R. Koller,et al.  Prognostic factors in adenocarcinoma of the cardia. , 1995, American journal of surgery.

[25]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[26]  Sunil Singhal,et al.  Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk , 2017, Annals of Surgical Oncology.

[27]  J. Hansen.  HEAD AND NECK , 2010 .

[28]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[29]  Siewert,et al.  [Cardia cancer: attempt at a therapeutically relevant classification]. , 1987, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.